Choose Retatrutide If: Maximum weight loss is the primary goal Previous GLP-1 agonists produced significant nausea (GIP component may help) No specific liver health concerns requiring treatment Tolerance for slightly higher GI side effects during titration Response to dual agonists (like tirzepatide) has been positive Choose Survodutide If: Liver health concerns exist (fatty liver, MASH, elevated liver enzymes) Moderate weight loss goals rather than maximum efficacy priority Interest in potential cardiovascular outcome benefits (CVOT data pending) Preference for a compound with FDA Breakthrough Therapy designation Plans to potentially transition to approved medication once available For most people focused primarily on weight loss, Retatrutide presents the stronger option based on available data
Backup supplies Extra dose of semaglutide in a separate insulated pouch
The BPC-157 guide , TB-500 guide , and ipamorelin benefits page provide information on these individual compounds
This delayed gastric emptying could theoretically affect alcohol absorption, though no formal pharmacokinetic studies have specifically examined this interaction
A healthy weight is a BMI of up to 25
Many users report that food becomes less interesting rather than unappetizing, a subtle but important distinction from the nausea-driven appetite suppression of GLP-1 medications
